Wealth Alliance Advisory Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Wealth Alliance Advisory Group's GILD Position: Q2 2026 in Review
Wealth Alliance Advisory Group increased its Gilead Sciences (GILD) stake by 2.8% in Q2 2026, buying an estimated $8.3K and bringing the position to 2,345 shares worth $296K. The position accounts for 0.04% of the portfolio, ranked #158.
Wealth Alliance Advisory Group first reported a position in GILD in Q1 2018 and has held it in 19 quarters since. The position peaked at $347K in Q1 2018. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Wealth Alliance Advisory Group held 2,345 shares of Gilead Sciences worth $296K as of Q2 2026.
- Wealth Alliance Advisory Group bought 63 Gilead Sciences shares in Q2 2026, an estimated $8.3K.
- Gilead Sciences made up 0.04% of Wealth Alliance Advisory Group's portfolio in Q2 2026, its #158 holding.
- Wealth Alliance Advisory Group first reported a position in Gilead Sciences in Q1 2018 and has held it in 19 quarters since.
- Wealth Alliance Advisory Group's Gilead Sciences position peaked at $347K in Q1 2018.
- 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Wealth Alliance Advisory Group's 13F filing for Q2 2026, filed 23 Jul 2026.